cvs glp-1 program is adding two weight loss options to its drug plans. They will start coverage of the pill starting June 1, and reinstate coverage of Zepbound Oct. 1. Click Watch Live cvs glp 1 program Impact
Description
Retatrutide represents the next frontier, targeting three receptors simultaneously: GLP-1, GIP, and glucagon
However, there is limited experience in patients with severe renal impairment or end-stage renal disease, so caution is advised
Common side effects may include nausea, bloating, diarrhea, constipation, or fatigue as your body adjusts
The Precision Peptide Genetic Test ($99 add-on after your first month) maps genetic variants in GLP1R, GIPR, FTO, and MC4R genes across 14 peptide pathways and 150+ insights
21 Alcohol: Can worsen nausea, potentially interact with the medication's effects on blood sugar or the liver, and contribute to dehydration
